Skip To The Main Content
background

PDA Standards Development

BSR/PDA Standard 02-201x, Cryopreservation of Cells for Use in Cell Therapies, Gene Therapies, and Regenerative Medicine Manufacturing

An Introduction and Best Practices Approach on How to Prepare, Cryopreserve, and Recover Cells, Cell Lines, and Cell-Based Tissue Products Available for Public Comment

The Parenteral Drug Association (PDA) would like to announce the availability of the draft document titled BSR/PDA Standard 02-201x, Cryopreservation of Cells for Use in Cell Therapies, Gene Therapies, and Regenerative Medicine Manufacturing: An Introduction and Best Practices Approach on How to Prepare, Cryopreserve, and Recover Cells, Cell Lines, and Cell-Based Tissue Products for public comment.

To receive a copy of this free draft, please complete the information in the form below.

Full name please
Current job title (optional)
Optional
 

Terms & Conditions

By submitting this form I agree that I have read and understood PDA’s Privacy Policy.

This standard is designed to provide guidance on best practice approaches to develop a robust protocol for the reliable freezing, storage, and recovery of cells intended for clinical applications. The public commenting period concludes on September 7, 2020.

All review comments must be submitted by the close of business on this date. All draft comments should be sent to [email protected].